InvestorsHub Logo
Followers 4
Posts 401
Boards Moderated 0
Alias Born 03/02/2006

Re: None

Tuesday, 12/09/2014 10:21:07 AM

Tuesday, December 09, 2014 10:21:07 AM

Post# of 346182
MPDL3280A, anti-PDL1 immune checkpoint therapy, with a discussion of the usefulness of genetic markers, and a little about how RECIST criteria may not take into account long term responses to immunotherapy. (May require log-in)

http://www.medpagetoday.com/HematologyOncology/OtherCancers/48990
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News